Skip to main content

Consolidated Lithium Metals Announces Closing of $8.9 Million Private Placement Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 10, 2026 (GLOBE NEWSWIRE) — Consolidated Lithium Metals Inc. (TSXV: CLM | FRA: Z36 | OTCQB: JORFF) (“CLM” or the “Company”) is pleased to announce that, further to its press release on March 18, 2026, it has closed the second and final tranche (the “Final Tranche”) of its previously announced non-brokered offering (the “Offering”) of securities of the Company. Together with the first tranche of the Offering, the Company obtained gross proceeds of approximately $8,935,320. In connection with the Final Tranche, the Company obtained aggregate gross proceeds of approximately $1,050,320 by issuing 10,940,830 flow-through shares of the Company (each, a “Critical FT Share”) at a price of $0.096 per Critical FT Share. Each Critical...

Continue reading

Tenaris Convenes the Annual General Meeting of Shareholders and an Extraordinary General Meeting of Shareholders

LUXEMBOURG, April 10, 2026 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announced today that has convened its Annual General Meeting of Shareholders to be held on May 12, 2026, at 10:00 (Central European time), and an Extraordinary General Meeting of Shareholders to be held immediately after the adjournment of the Annual General Meeting of Shareholders. The convening notice (which includes the agendas for the meetings and the procedure for attending and/or voting at the meetings) was published in such newspapers and filed with the regulators, as required by applicable law, and is available on the Luxembourg Stock Exchange’s website at www.bourse.lu/regulated-information-oam, the SEC’s website at www.sec.gov, and Tenaris’s website at ir.tenaris.com. The following documents are also available on Tenaris’s...

Continue reading

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) for the Company’s Biologics License Application (BLA) for RP1 in combination with nivolumab for the treatment of advanced melanoma. Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced cancer patients. In the IGNYTE trial, patients with confirmed progression on an anti-PD-1 based regimen who received RP1 plus nivolumab had a 34% response rate with a median duration of 24.8 months...

Continue reading

Lithium Ionic Provides Update

TORONTO, April 10, 2026 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) is is aware of the Ontario Securities Commission’s publication regarding a regulatory matter involving another reporting issuer and individuals who have, or have had, an association with the Company. Lithium Ionic is not a respondent in this matter and no orders have been sought against Lithium Ionic. The allegations contained in the proceeding have not been proven. The Board of Directors has established a Special Committee of independent directors to oversee the Company’s communications and disclosure in respect of this matter. About Lithium Ionic Corp. Lithium Ionic is a Canadian lithium development company focused on responsibly advancing its 100%-owned Bandeira Lithium...

Continue reading

Pelthos Therapeutics Announces CFO Transition

Senior Vice President, Finance & Accounting John M. Gay named Chief Financial Officer DURHAM, N.C., April 10, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced John M. Gay has been appointed Chief Financial Officer effective April 10, 2026. Mr. Gay succeeds Francis Knuettel II, who served as Pelthos’ Chief Financial Officer since July 2025. “John played a key role in helping us establish and launch Pelthos. He is an experienced financial leader, and we are excited to have him step into this new role as we continue our strong commercial momentum and enter the next phase of the company’s growth,” said Scott Plesha, CEO of Pelthos. “We also want to thank Frank...

Continue reading

UPDATE — Aeroméxico Announces Webcast of First Quarter 2026 Financial Results

MEXICO CITY, April 10, 2026 (GLOBE NEWSWIRE) — Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeroméxico”) will hold a live conference call and webcast on Wednesday, April 22, 2026, at 10:30 a.m. Mexico City Time (12:30 p.m. Eastern Time) to discuss its first quarter 2026 financial results. During the call, management will review the company’s operating and financial performance for the period, highlighting key business drivers, recent developments, and strategic initiatives that shaped Aeroméxico’s results throughout the first quarter. The event will also include a Q&A session for investors and analysts. A live webcast of this event will be available at https://ir.aeromexico.com/ and an online replay will be available shortly after the webcast is complete. The company’s first quarter 2026 earnings results...

Continue reading

TC Energy to host first quarter 2026 conference call on May 1 and hold annual meeting of common shareholders on May 7

CALGARY, Alberta, April 10, 2026 (GLOBE NEWSWIRE) — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) will hold a teleconference and webcast on Friday, May 1, 2026 to discuss its first quarter financial results, and hold its 2026 annual meeting of common shareholders on Thursday, May 7, 2026. First quarter 2026 financial resultsFrançois Poirier, TC Energy President and Chief Executive Officer, Sean O’Donnell, Executive Vice-President and Chief Financial Officer, and other members of the executive leadership team will discuss the financial results and Company developments on Friday, May 1 at 6:30 a.m. MT / 8:30 a.m. ET. Members of the investment community and other interested parties are invited to participate by calling 1-833-752-3826 (Canada/U.S. toll free) or 1-647-846-8864 (International toll). No passcode is...

Continue reading

Kinross recommends shareholders reject TRC Capital Investment’s below-market “mini-tender” offer for common shares

TORONTO, April 10, 2026 (GLOBE NEWSWIRE) — Kinross Gold Corporation (TSX: K; NYSE: KGC) (the “Company”) received notification that TRC Capital Investment Corporation (“TRC”) has made an unsolicited “mini-tender” offer on April 7, 2026, to purchase up to 2.5 million common shares of Kinross, or approximately 0.21% of Kinross’ shares outstanding, at a price of C$41.75 per share. Kinross strongly recommends that its shareholders reject this offer and cautions its shareholders that the offer made is approximately 4.4% below the closing price of C$43.68 per Kinross share on the Toronto Stock Exchange on April 6, 2026, the day before the offer. Kinross does not endorse TRC’s unsolicited mini-tender offer, and is not affiliated or associated in any way with TRC Capital Investment. TRC has made several similar unsolicited mini-tender offers...

Continue reading

The Children’s Place Reports Fourth Quarter and Full Year 2025 Results

Improvement in Operating Cash Flows by $126 million during Fiscal 2025 versus Fiscal 2024 SECAUCUS, N.J., April 10, 2026 (GLOBE NEWSWIRE) — The Children’s Place, Inc. (Nasdaq: PLCE), one of the only pure-play children’s specialty retailers in North America with an omni-channel presence, today announced financial results for the Company’s fourth fiscal quarter and the full fiscal year ended January 31, 2026. Muhammad Umair, President and Chief Executive Officer said, “While our fourth quarter results were disappointing, we are taking decisive action to turn this business around. The Children’s Place brand remains strong, recently ranked 21st in TIME’s survey of “America’s most iconic companies”, and we are leveraging that foundation to drive our transformation. We are reigniting what makes our brand unique by delivering compelling...

Continue reading

Artisan Partners Asset Management Inc. Reports March 2026 Assets Under Management

MILWAUKEE, April 10, 2026 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management (“AUM”) as of March 31, 2026 totaled $173.0 billion. Artisan Funds and Artisan Global Funds accounted for $84.5 billion of total firm AUM, while separate accounts and other AUM1 accounted for $88.5 billion.PRELIMINARY ASSETS UNDER MANAGEMENT BY STRATEGY2         As of March 31, 2026 – ($ Millions)    Growth Team    Global Opportunities $14,340  Global Discovery 1,026  U.S. Mid-Cap Growth 9,364  U.S. Small-Cap Growth 2,642  Franchise 911  Global Equity Team    Global Equity 393  Non-U.S. Growth 15,456  U.S. Value Team    Value Equity 5,600  U.S. Mid-Cap Value 1,898  Value Income 8  International Value Group    International...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.